Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study

INTRODUCTION: The aim of this study was to assess the efficacy and safety of fluocinolone acetonide implant (FAci) injected 1 month after the last dexamethasone intravitreal implant (DEXi) in chronic diabetic macular oedema (DME) patients. METHODS: Retrospective multicentric study conducted in pseud...

Descripción completa

Detalles Bibliográficos
Autores principales: Rousseau, Nicolas, Lebreton, Olivier, Masse, Hélène, Maucourant, Yann, Pipelart, Valentin, Clement, Manon, Le Lez, Marie-Laure, Khanna, Raoul Kanav, Pepin, Maxime, Eude, Yannick, Le Meur, Guylène, Weber, Michel, Ducloyer, Jean-Baptiste
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441852/
https://www.ncbi.nlm.nih.gov/pubmed/37369907
http://dx.doi.org/10.1007/s40123-023-00749-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441852/
https://www.ncbi.nlm.nih.gov/pubmed/37369907
http://dx.doi.org/10.1007/s40123-023-00749-2

Ejemplares similares